TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM)
NCT07355257
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Inflammatory Myopathy
Interventions
DRUG:
Telitacicept 240mg
Sponsor
Zhongming Qiu